{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T06:20:34Z","timestamp":1791440434571,"version":"4.3.3"},"reference-count":61,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,2,4]],"date-time":"2025-02-04T00:00:00Z","timestamp":1738627200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>The prognostic value of the systemic immune-inflammation index (SII) for prostate cancer (PCa) patients receiving different treatments remains unclear. This research examined the relevance of SII in individuals undergoing radical prostatectomy (RP).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>PubMed, Embase, Web of Science, Cochrane, Wanfang, and China National Knowledge Infrastructure (CNKI) dat3 abases were used to search literature up to May 2024. The quality was evaluated with Newcastle-Ottawa Scale. Outcomes examined were associations between SII and overall survival (OS), biochemical recurrence-free survival (BFS), and cancer-specific survival (CSS). Pooled analysis, Egger\u2019s test, and sensitivity analysis were conducted using Review Manager 5.4.1 and Stata 15.1. The GRADE system was employed to evaluate and grade the evidence for each outcome. Subgroup analyses were performed for outcomes with significant heterogeneity to evaluate the possible confounders, if data were sufficient.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Out of 101 identified studies, eight studies involving 8,267 individuals were included. Patients with higher SII had shorter overall survival (HR: 1.89; 95% CI: 1.31-2.71; P = 0.0006), biochemical recurrence-free survival (HR: 1.55; 95% CI: 1.08-2.22; P = 0.02), and cancer-specific survival (HR: 3.63; 95% CI: 1.66-7.94; P = 0.001). The evidence for OS and CSS was rated very low-quality due to serious heterogeneity and\/or imprecision. The prognostic value of SII for BFS was rated as low-quality evidence, given no serious risk observed. Subgroup analysis showed that, except for the subgroup aged &amp;gt;65 years (HR: 3.70; 95%CI: 0.91, 15.06,\n                      <jats:italic>P<\/jats:italic>\n                      =0.07), the prognostic value of SII for OS was not significant, but the prognostic value of SII for OS in other subgroups was still significant.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>High SII was linked to shorter OS, BFS, and CSS in patients undergoing RP. However, the quality of the evidence provided by this study was low.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Systematic Review Registration<\/jats:title>\n                    <jats:p>\n                      <jats:uri>https:\/\/www.crd.york.ac.uk\/PROSPERO\/<\/jats:uri>\n                      , identifier CRD42024558431.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2025.1465971","type":"journal-article","created":{"date-parts":[[2025,2,4]],"date-time":"2025-02-04T01:31:42Z","timestamp":1738632702000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":8,"title":["Prognostic value of systemic immune-inflammation index for patients undergoing radical prostatectomy: a systematic review and meta-analysis"],"prefix":"10.3389","volume":"16","author":[{"given":"Zhan","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,2,4]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA: Cancer J Clin"},{"key":"B2","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3322\/caac.21763","article-title":"Cancer statistics, 2023","volume":"73","author":"Siegel","year":"2023","journal-title":"CA Cancer J Clin"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1615869","article-title":"Follow-up of prostatectomy versus observation for early prostate cancer","volume":"377","author":"Wilt","year":"2017","journal-title":"New Engl J Med"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2018.10.011","article-title":"Prognostic value of biochemical recurrence following treatment with curative intent for prostate cancer: a systematic review","volume":"75","author":"Van den Broeck","year":"2019","journal-title":"Eur urology"},{"key":"B5","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.eururo.2018.01.001","article-title":"Focal therapy in primary localised prostate cancer: the european association of urology position in 2018","volume":"74","author":"van der Poel","year":"2018","journal-title":"Eur Urol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-021-07001-6","article-title":"High neutrophil\u2013lymphocyte ratio and delta neutrophil\u2013lymphocyte ratio are associated with increased mortality in patients with hepatocellular cancer","volume":"67","author":"Rich","year":"2022","journal-title":"Digestive Dis Sci"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.3390\/cancers13061210","article-title":"The combination of neutrophil\u2013lymphocyte ratio and platelet\u2013lymphocyte ratio with liquid biopsy biomarkers improves prognosis prediction in metastatic pancreatic cancer","volume":"13","author":"Toledano-Fonseca","year":"2021","journal-title":"Cancers"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.00841","article-title":"Prognostic value of neutrophil\u2013lymphocyte ratio, platelet\u2013lymphocyte ratio, and combined neutrophil\u2013lymphocyte ratio and platelet\u2013lymphocyte ratio in stage IV advanced gastric cancer","volume":"10","author":"Wang","year":"2020","journal-title":"Front Oncol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12885-020-07700-9","article-title":"Dynamic changes of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio predicts breast cancer prognosis","volume":"20","author":"Kim","year":"2020","journal-title":"BMC cancer"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.4103\/atm.ATM_382_20","article-title":"Prognostic utility of inflammation-based biomarkers, neutrophil\u2013lymphocyte ratio and change in neutrophil\u2013lymphocyte ratio, in surgically resected lung cancers","volume":"16","author":"Thompson","year":"2021","journal-title":"Ann Thorac Med"},{"key":"B11","article-title":"Is early change in systemic inflammatory markers associated with treatment response in patients who received pazopanib","volume":"27","author":"Erdogan","year":"2021","journal-title":"Lung"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-14-0442","article-title":"Systemic immune-inflammation index predicts prognosis of patients after curative resection for hepatocellular carcinoma","volume":"20","author":"Hu","year":"2014","journal-title":"Clin Cancer Res"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2017.460","article-title":"Systemic immune-inflammation index in germ-cell tumours","volume":"118","author":"Chovanec","year":"2018","journal-title":"Br J cancer"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1007\/s00345-021-03740-3","article-title":"Prognostic value of the systemic immune-inflammation index in non-muscle invasive bladder cancer","volume":"39","author":"Katayama","year":"2021","journal-title":"World J Urology"},{"key":"B15","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1186\/s12885-024-12593-z","article-title":"Analysis of the immune-inflammatory indices for patients with metastatic hormone-sensitive and castration-resistant prostate cancer","volume":"24","author":"Wang","year":"2024","journal-title":"BMC Cancer"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.21037\/tau-24-155","article-title":"Establishing a model predicting Gleason grade group upgrading in prostate cancer","volume":"13","author":"Chen","year":"2024","journal-title":"Transl Androl Urol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1111\/bju.16597","article-title":"Utility of PSA free-to-total ratio for clinically significant prostate cancer in men with a PSA level of <4\u2009ng\/mL","author":"Sii","year":"2024","journal-title":"BJU Int"},{"key":"B18","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/s12967-023-03924-y","article-title":"Prognostic value of the pretreatment systemic immune-inflammation index in patients with prostate cancer: a systematic review and meta-analysis","volume":"21","author":"Meng","year":"2023","journal-title":"J Transl Med"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.3390\/cancers15061869","article-title":"Systemic inflammation indices and association with prostate cancer survival in a diverse patient cohort","volume":"15","author":"Bailey-Whyte","year":"2023","journal-title":"Cancers"},{"key":"B20","doi-asserted-by":"publisher","first-page":"785.e19","DOI":"10.1016\/j.urolonc.2021.05.002","article-title":"Impact of systemic Immune-inflammation Index on oncologic outcomes in patients treated with radical prostatectomy for clinically nonmetastatic prostate cancer","volume":"39","author":"Rajwa","year":"2021","journal-title":"Urologic Oncology: Semin Original Investigations"},{"key":"B21","first-page":"n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ (Clinical Res ed)"},{"key":"B22","unstructured":"The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses\n          \n          \n            \n              Wells\n              G\n            \n            \n              Shea\n              B\n            \n            \n              O\u2019Connell\n              D\n            \n            \n              Peterson\n              J\n            \n            \n              Welch\n              V\n            \n            \n              Losos\n              M\n            \n          \n          \n          2011"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.3390\/nu11040826","article-title":"Effect of red, processed, and white meat consumption on the risk of gastric cancer: an overall and dose\u207bResponse meta-analysis","volume":"11","author":"Kim","year":"2019","journal-title":"Nutrients"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1002\/sim.v21:11","article-title":"Quantifying heterogeneity in a meta-analysis","volume":"21","author":"Higgins","year":"2002","journal-title":"Stat Med"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ (Clinical Res ed)"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2010.04.026","article-title":"GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables","volume":"64","author":"Guyatt","year":"2011","journal-title":"J Clin Epidemiol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1007\/s00345-021-03715-4","article-title":"Role of systemic immune-inflammation index in patients treated with salvage radical prostatectomy","volume":"39","author":"Rajwa","year":"2021","journal-title":"World J urology"},{"key":"B28","article-title":"Prediction of biochemical recurrence of prostate cancer after operation by systematic immunoinflammatory index and monocyte-lymphocyte ratio","volume":"43","author":"Shi","year":"2023","journal-title":"Int J Urol Nephrology"},{"key":"B29","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1186\/s12894-023-01379-3","article-title":"Predictive value of systematic immune-inflammation index combined with Ki-67 index on prognosis of prostate cancer patients after laparoscopic radical prostatectomy","volume":"23","author":"Wu","year":"2023","journal-title":"BMC Urology"},{"key":"B30","volume-title":"The value of preoperative inflammatory markers NLR and SII for prognosis after radical prostatectomy","author":"Yao","year":"2022"},{"key":"B31","doi-asserted-by":"crossref","first-page":"4135","DOI":"10.3390\/cancers14174135","article-title":"The clinical utility of systemic immune-inflammation index supporting charlson comorbidity index and CAPRA-S score in determining survival after radical prostatectomy-A single centre study","volume":"14","author":"Zapala","year":"2022","journal-title":"Cancers"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12967-017-1326-1","article-title":"Systemic immune-inflammation index predicting chemoradiation resistance and poor outcome in patients with stage III non-small cell lung cancer","volume":"15","author":"Tong","year":"2017","journal-title":"J Trans Med"},{"key":"B33","doi-asserted-by":"publisher","first-page":"54564","DOI":"10.18632\/oncotarget.10515","article-title":"Systemic immune-inflammation index predicts the clinical outcome in patients with metastatic renal cell cancer treated with sunitinib","volume":"7","author":"Lolli","year":"2016","journal-title":"Oncotarget"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1007\/s11255-019-02265-4","article-title":"Systemic immune-inflammation index, serum albumin, and fibrinogen impact prognosis in castration-resistant prostate cancer patients treated with first-line docetaxel","volume":"51","author":"Man","year":"2019","journal-title":"Int Urol Nephrol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.865643","article-title":"The prognostic and clinicopathological significance of systemic immune-inflammation index in bladder cancer","volume":"13","author":"Li","year":"2022","journal-title":"Front Immunol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1126\/science.1092385","article-title":"Neutrophil extracellular traps kill bacteria","volume":"303","author":"Brinkmann","year":"2004","journal-title":"science"},{"key":"B37","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1152\/physrev.00062.2021","article-title":"Neutrophil extracellular traps in the pathology of cancer and other inflammatory diseases","volume":"103","author":"Herre","year":"2023","journal-title":"Physiol Rev"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1126\/science.1095484","article-title":"The tangled webs that neutrophils weave","volume":"303","author":"Lee","year":"2004","journal-title":"Science"},{"key":"B39","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.3390\/ijms23031257","article-title":"Neutrophils, cancer and thrombosis: the new Bermuda triangle in cancer research","volume":"23","author":"Langiu","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1038\/nrc.2016.52","article-title":"Neutrophils in cancer: neutral no more","volume":"16","author":"Coffelt","year":"2016","journal-title":"Nat Rev Cancer"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1172\/JCI143759","article-title":"Neutrophil dynamics in the tumor microenvironment","volume":"131","author":"McFarlane","year":"2021","journal-title":"J Clin Invest"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1007\/s10555-015-9594-9","article-title":"Neutrophils: important contributors to tumor progression and metastasis","volume":"34","author":"Swierczak","year":"2015","journal-title":"Cancer Metastasis Rev"},{"key":"B43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13045-021-01187-y","article-title":"Neutrophils in cancer carcinogenesis and metastasis","volume":"14","author":"Xiong","year":"2021","journal-title":"J Hematol Oncol"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdy004","article-title":"Prognostic and predictive role of neutrophil\/lymphocytes ratio in metastatic colorectal cancer: a retrospective analysis of the TRIBE study by GONO","volume":"29","author":"Dell\u2019Aquila","year":"2018","journal-title":"Ann Oncol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.22.00284","article-title":"Challenges of creating new tumor-infiltrating lymphocyte for combating breast cancer","volume":"40","author":"Beavis","year":"2022","journal-title":"J Clin Oncol"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-022-01291-2","article-title":"Eosinophil\u2013lymphocyte interactions in the tumor microenvironment and cancer immunotherapy","volume":"23","author":"Grisaru-Tal","year":"2022","journal-title":"Nat Immunol"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2010.01.025","article-title":"Immunity, inflammation, and cancer","volume":"140","author":"Grivennikov","year":"2010","journal-title":"Cell"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1038\/nrc3004","article-title":"Contribution of platelets to tumour metastasis","volume":"11","author":"Gay","year":"2011","journal-title":"Nat Rev Cancer"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2011.11.001","article-title":"Platelets alter tumor cell attributes to propel metastasis: programming in transit","volume":"20","author":"Gay","year":"2011","journal-title":"Cancer Cell"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2018.03.002","article-title":"The platelet lifeline to cancer: challenges and opportunities","volume":"33","author":"Haemmerle","year":"2018","journal-title":"Cancer Cell"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2011.09.009","article-title":"Direct signaling between platelets and cancer cells induces an epithelial-mesenchymal-like transition and promotes metastasis","volume":"20","author":"Labelle","year":"2011","journal-title":"Cancer Cell"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2016.11.037","article-title":"Emerging biological principles of metastasis","volume":"168","author":"Lambert","year":"2017","journal-title":"Cell"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1007\/s10555-017-9673-1","article-title":"Platelets and cancer angiogenesis nexus","volume":"36","author":"Wojtukiewicz","year":"2017","journal-title":"Cancer Metastasis Rev"},{"key":"B54","doi-asserted-by":"publisher","first-page":"549","DOI":"10.3390\/cancers14030549","article-title":"Platelet count and survival after cancer","volume":"14","author":"Giannakeas","year":"2022","journal-title":"Cancers"},{"key":"B55","doi-asserted-by":"publisher","first-page":"S1078","DOI":"10.1016\/j.urolonc.2024.06.003","article-title":"Prostate-specific antigen screening for prostate cancer: Diagnostic performance, clinical thresholds, and strategies for refinement","volume":"16","author":"Sundaresan","year":"2024","journal-title":"Urol Oncol"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1057\/s41271-024-00502-4","article-title":"PSA screening for prostate cancer in the United States: 30 years of controversy","volume":"45","author":"Georgiou","year":"2024","journal-title":"J Public Health Policy"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1111\/eci.13230","article-title":"Systemic immune-inflammation index (SII) predicted clinical outcome in patients with coronary artery disease","volume":"50","author":"Yang","year":"2020","journal-title":"Eur J Clin Invest"},{"key":"B58","doi-asserted-by":"publisher","first-page":"397","DOI":"10.2147\/CIA.S397614","article-title":"Prognostic value of systemic immune-inflammation index and NT-proBNP in patients with acute ST-elevation myocardial infarction","volume":"18","author":"Zhu","year":"2023","journal-title":"Clin Interv Aging"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.48101\/ujms.v126.8124","article-title":"Assessing the relationship between systemic immune-inflammation index and mortality in patients with hypertrophic cardiomyopathy","volume":"126","author":"Wang","year":"2021","journal-title":"Ups J Med Sci"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1016\/j.ihj.2023.10.008","article-title":"Comparison of neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), and systemic immune-inflammation index (SII) as marker of adverse prognosis in patients with infective endocarditis","volume":"75","author":"Thottuvelil","year":"2023","journal-title":"Indian Heart J"},{"key":"B61","volume-title":"Preoperative systemic immune-inflammation index in predicting biochemical recurrence after radical prostatectomy: a clinical study","author":"Li","year":"2023"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1465971\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,4]],"date-time":"2025-02-04T01:31:47Z","timestamp":1738632707000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1465971\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,4]]},"references-count":61,"alternative-id":["10.3389\/fimmu.2025.1465971"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1465971","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,4]]},"article-number":"1465971"}}